FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mireia Arnedo

Research Profile

Disorders

Living Beings

HIV-1

Procedures

Concepts & Ideas

Chemicals & Drugs

Physiology

Anatomy

Co-author Network

Publications

TOP 3
Lander Egaña-Gorroño; Tuixent Escribà; Jose Gatell; Esteban Martínez; Bru Cormand; Mireia Arnedo
Impact of genetic factors on dyslipidemia in HIV-infected patients starting antiretroviral therapy.
Mireia Arnedo; David Dalmau; Nell Eisenberg; Cecilia Ferreyra; Laurence Flevaud; Jose Maria Gatell; Laura Ibáñez; Angels Jaén; Samuel Khamadi; Paul Roddy; Elena Alonso
Monitoring HIV viral load in resource limited settings: still a matter of debate?
Cecilia Ferreyra; Laurence Flevaud; Ashimosi S Khamadi; Martha Kihara Mugendi; Matilu Mwau; Elena Alonso; Ana Alvarez; Mireia Arnedo; Andrea Bernasconi; David Dalmau; Nell Eisenberg; Paul Roddy; Elena Velilla; Oliver Yun; Pedro Pablo Palma
Evaluation of clinical and immunological markers for predicting virological failure in a HIV/AIDS treatment cohort in Busia, Kenya.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mireia Arnedo (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Lander Egaña-Gorroño; Tuixent Escribà; Jose Gatell; Esteban Martínez; Bru Cormand; Mireia Arnedo
Impact of genetic factors on dyslipidemia in HIV-infected patients starting antiretroviral therapy.
AIDS (London, England) 2013;27(4):529-38.
2012: Mireia Arnedo; David Dalmau; Nell Eisenberg; Cecilia Ferreyra; Laurence Flevaud; Jose Maria Gatell; Laura Ibáñez; Angels Jaén; Samuel Khamadi; Paul Roddy; Elena Alonso
Monitoring HIV viral load in resource limited settings: still a matter of debate?
PloS one 2012;7(12):e47391.
2012: Cecilia Ferreyra; Laurence Flevaud; Ashimosi S Khamadi; Martha Kihara Mugendi; Matilu Mwau; Elena Alonso; Ana Alvarez; Mireia Arnedo; Andrea Bernasconi; David Dalmau; Nell Eisenberg; Paul Roddy; Elena Velilla; Oliver Yun; Pedro Pablo Palma
Evaluation of clinical and immunological markers for predicting virological failure in a HIV/AIDS treatment cohort in Busia, Kenya.
PloS one 2012;7(11):e49834.
2012: Francesc Vidal; Gloria Sampériz; Sergi Veloso; Mireia Arnedo; Teresa Auguet; Carmen Cifuentes; Lluis Gallart; Josep Ma Gatell; Pilar Hernandez; Montserrat Laguno; Miguel López-Dupla; Josep Mallolas; Javier Murillas; Antoni Payeras; Cristóbal Richart
Pharmacogenetics of efficacy and safety of HCV treatment in HCV-HIV coinfected patients: significant associations with IL28B and SOCS3 gene variants.
PloS one 2012;7(11):e47725.
2011: Francesc Vidal; Consuelo Viladés; Francesc Villarroya; Manuel Leal; Joaquim Peraire; José Alcamí; Mireia Arnedo; Pere Domingo; Josep Ma Gatell
Pharmacogenetics of the lipodystrophy syndrome associated with HIV infection and combination antiretroviral therapy.
Expert opinion on drug metabolism & toxicology 2011;7(11):1365-82.
2011: Millán Ortiz; Estella S Poloni; Hansjakob Furrer; Helen Kovari; Raquel Martinez; Mireia Arnedo; Luigia Elzi; Enos Bernasconi; Pietro Vernazza; Bernard Hirschel; Matthias Cavassini; bruno ledergerber; Huldrych Günthard; Amalio Telenti; Philip E Tarr
No longitudinal mitochondrial DNA sequence changes in HIV-infected individuals with and without lipoatrophy.
The Journal of infectious diseases 2011;203(5):620-4.
2009: Anna López; Nils van der Lubbe; Sonsoles Sánchez-Palomino; Mireia Arnedo; Meritxell Nomdedeu; Pedro Castro; Meritxell Guilà; Maria J Maleno; Felipe García; Teresa Gallart; José M Gatell; Montserrat Plana
Phenotypic and functional characteristics of HIV-specific CD8 T cells and gag sequence variability after autologous dendritic cells based therapeutic vaccine.
Vaccine 2009;27(44):6166-78.
2007: Mireia Arnedo; Patrick Taffé; Roland Sahli; Hansjakob Furrer; Bernard Hirschel; Luigia Elzi; Rainer Weber; Pietro Vernazza; Enos Bernasconi; Roger Darioli; Sven Bergmann; Jacques Beckmann; Amalio Telenti; Philip E Tarr
Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy.
Pharmacogenetics and genomics 2007;17(9):755-64.
2007: Josep Mallolas; Jl Blanco; Pablo Labarga; Antonio Vergara; Antonio Ocampo; María Sarasa; Mireia Arnedo; Y López-Púa; J García; J Juega; Ana Guelar; Alberto Terrón; David Dalmau; I García; M Zárraga; Esteban Martínez; Xavier Carné; Tomás Pumarola; R Escayola; José M Gatell
Inhibitory quotient as a prognostic factor of response to a salvage antiretroviral therapy containing ritonavir-boosted saquinavir. The CIVSA Study.
HIV medicine 2007;8(4):226-33.
2006: Agnès Libois; Anna López; Felipe Garcia; Pedro Castro; María J Maleno; Ana García; Nuria Climent; Mireia Arnedo; Teresa Gallart; José M Gatell; Montserrat Plana
Dynamics of T cells subsets and lymphoproliferative responses during structured treatment interruption cycles and after definitive interruption of HAART in early chronic HIV type-1-infected patients.
AIDS research and human retroviruses 2006;22(7):657-66.
2006: Omar Sued; José M Miró; Aitor Alquezar; Xavier Claramonte; Felipe García; Montserrat Plana; Mireia Arnedo; Elisa De Lazzari; Cristina Gil; Christian Manzardo; José L Blanco; Esteban Martínez; Josep Mallolas; Joan Joseph; Tomás Pumarola; Teresa Gallart; José M Gatell
Primary human immunodeficiency virus type 1 infection: clinical, virological and immunological characteristics of 75 patients (1997-2003).
Enfermedades infecciosas y microbiología clínica 2006;24(4):238-44.
2006: Josep Mallolas; Mireia Arnedo; Tomás Pumarola; Alejo Erice; José L Blanco; Esteban Martínez; José M Gatell
Transmission of HIV-1 from an obstetrician to a patient during a caesarean section.
AIDS (London, England) 2006;20(2):285-7.
2005: Anna Ochoa de Echagüen; Mireia Arnedo; Mariona Xercavins; Esteban Martinez; Beatriz Rosón; Esteban Ribera; Pere Domingo; Alicia González; Melcior Riera; Josep M Llibre; José M Gatell; David Dalmau
Genotypic and phenotypic resistance patterns at virological failure in a simplification trial with nevirapine, efavirenz or abacavir.
AIDS (London, England) 2005;19(13):1385-91.
2005: José L Blanco; M Alejandra Biglia; Mireia Arnedo; Esteban Martínez; Josep Mallolas; Ana Milinkovic; Montserrat Laguno; María Larrousse; Agathe Leon; Montserrat Lonca; Felipe García; José M Miró; Tomás Pumarola; José M Gatell
Evolution of resistance mutations pattern in HIV-1-infected patients during intensification therapy with a boosted protease inhibitor.
AIDS (London, England) 2005;19(8):829-31.
2004: Eric Florence; Felipe García; Montserrat Plana; Emilio Fumero; Pedro Castro; Anna Lopez; Anna Cruceta; Cristina Gil; Mireia Arnedo; José M Miró; Tomás Pumarola; Teresa Gallart; José M Gatell
Long-term clinical follow-up, without antiretroviral therapy, of patients with chronic HIV-1 infection with good virological response to structured treatment interruption.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(4):569-74.
2004: Felipe García; Montserrat Plana; Mireia Arnedo; Mercè Brunet; Pedro Castro; Cristina Gil; Elena Vidal; Olga Millán; Anna López; Jaume Martorell; Emilio Fumero; José M Miró; José Alcamí; Tomás Pumarola; Teresa Gallart; José M Gatell
Effect of mycophenolate mofetil on immune response and plasma and lymphatic tissue viral load during and after interruption of highly active antiretroviral therapy for patients with chronic HIV infection: a randomized pilot study.
Journal of acquired immune deficiency syndromes (1999) 2004;36(3):823-30.
2004: Montserrat Plana; Felipe Garcia; Annette Oxenius; Gabriel M Ortiz; Anna Lopez; Anna Cruceta; Gabriel Mestre; Emilio Fumero; Catherine Fagard; Maria Antonia Sambeat; Ferran Segura; José M Miró; Mireia Arnedo; Lucia Lopalcos; Tomás Pumarola; Bernard Hirschel; Rodney E Phillips; Douglas F Nixon; Teresa Gallart; José M Gatell
Relevance of HIV-1-specific CD4+ helper T-cell responses during structured treatment interruptions in patients with CD4+ T-cell nadir above 400/mm3.
Journal of acquired immune deficiency syndromes (1999) 2004;36(3):791-9.
2003: Pilar Navarrete; Vanesa Morente; Felipe García; Llucia Alós; Mireia Arnedo; Montserrat Plana; Cristina Gil; Miguel Caballero; José M Miró; Esteban Martínez; Emilio Fumero; Pedro Castro; José L Blanco; Josep Mallolas; Jordi Blanch; Anna Cruceta; Gabriel Mestre; Tomás Pumarola; Teresa Gallart; José M Gatell
Predictors of tonsillar tissue HIV-1 viral burden at baseline and after 1 year of antiretroviral therapy.
Antiviral therapy 2003;8(6):635-7.
2003: Elena Ferrer; Daniel Podzamczer; Mireia Arnedo; Emilio Fumero; Paula McKenna; Alex Rinehart; José L Pérez; María J Barberá; Tomás Pumarola; José M Gatell; Francesc Gudiol
Genotype and phenotype at baseline and at failure in human immunodeficiency virus-infected antiretroviral-naive patients in a randomized trial comparing zidovudine and lamivudine plus nelfinavir or nevirapine.
The Journal of infectious diseases 2003;187(4):687-90.
2003: Felipe García; Montserrat Plana; Mireia Arnedo; Gabriel M Ortiz; José M Miró; Lucia Lopalco; Franco Lori; Tomás Pumarola; Teresa Gallart; José M Gatell
A cytostatic drug improves control of HIV-1 replication during structured treatment interruptions: a randomized study.
AIDS (London, England) 2003;17(1):43-51.
2002: Carme Vidal; Mireia Arnedo; Felipe Garcia; Gabriel Mestre; Montserrat Plana; Anna Cruceta; Alicia Capon; Teresa Gallart; José M Miro; Tomás Pumarola; José M Gatell
Genotypic and phenotypic resistance patterns in early-stage HIV-1-infected patients failing initial therapy with stavudine, didanosine and nevirapine.
Antiviral therapy 2002;7(4):283-7.
2002: Felipe García; Montserrat Plana; Gabriel Mestre; Mireia Arnedo; Cristina Gil; José M Miró; Anna Cruceta; Tomás Pumarola; Teresa Gallart; José M Gatell
Immunological and virological factors at baseline may predict response to structured therapy interruption in early stage chronic HIV-1 infection.
AIDS (London, England) 2002;16(13):1761-5.
2001: Esteban Martínez; Mireia Arnedo; Vicente Giner; Cristina Gil; Miguel Caballero; Llucia Alós; Felipe García; C Holtzer; Josep Mallolas; José M Miró; Tomás Pumarola; José M Gatell
Lymphoid tissue viral burden and duration of viral suppression in plasma.
AIDS (London, England) 2001;15(12):1477-82.
2001: Felipe García; Montserrat Plana; Gabriel M Ortiz; Sebastian Bonhoeffer; A Soriano; Carme Vidal; Anna Cruceta; Mireia Arnedo; Cristina Gil; G Pantaleo; Tomás Pumarola; Teresa Gallart; D F Nixon; José M Miró; José M Gatell
The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection.
AIDS (London, England) 2001;15(9):F29-40.
2001: Felipe Garcia; Montserrat Plana; A Soriano; Carme Vidal; Mireia Arnedo; Cristina Gil; Anna Cruceta; Tomás Pumarola; Teresa Gallart; José M Miro; José M Gatell
Predictors of progression in chronically infected naive patients with plasma viraemia below 5000 copies/ml and CD4 T lymphocytes greater than 500 x 10(6)/I.
AIDS (London, England) 2001;15(1):131-3.